Skip to main content
. 2017 Mar 18;8(19):31494–31508. doi: 10.18632/oncotarget.16357

Figure 5.

Figure 5

Associations between positive FAM13C immunostaining and PTEN, 5q21 (CHD1), 6q15 (MAP3K7), 3p13 (FOXP1) – deletion status in (1) all cancers, in (2) ERG fusion negative cancers and (3) ERG fusion positive cancer.